Navigation Links
Antithrombotic/Anticoagulant Drugs: World Market 2012-2022
Date:5/3/2012

Risk Factors: Management Rather Than Cure

7.1.3 Opportunities for Continuous Growth

7.1.3.1 Standing Out from Competitors

7.1.3.2 Cost-Effective Replacement of Warfarin

7.1.3.3 Antidotes in Demand

7.1.3.4 Further Development of Existing Drugs

7.1.3.5 Exploring New Markets

7.1.4 Advances in Technology Will Bring Benefits to the Market

7.2 Principal Market Restraints

7.2.1 Highly Competitive Market

7.2.1.1 Generic Competition

7.2.1.2 Branded Competition

7.2.2 Cost-Reduction Pressure

7.2.3 Stringent Regulations

 

8. Research Interviews

8.1 Interview with Dr Charles E. Mahan (Director of Outcomes Research, New Mexico Heart Institute,Albuquerque, New Mexico)

8.1.1 Unmet Needs

8.1.2 Major Areas of Focus

8.1.3 New Drug Potential

8.1.4 Key Market Drivers

8.1.5 Opportunities for Revenue Growth

8.2 Interview with Dr Maurice Petitou (Head of Preclinical Research and Development, Endotis Pharma)

8.2.1 EP217609: The First Neutralizable Anticoagulant

8.2.2 Drug Targets Worth Exploring

8.2.3 New Drug Potential

8.2.4 Unmet Needs

8.3 Interview with Dr Jonathan L. Halperin (Professor of Medicine, Director of Clinical Cardiology Services, Zena and Michael A. Wiener Cardiovascular Institute, The Mount Sinai Medical Center, New York)

8.3.1 Unmet Needs

8.3.2 New Findings

8.3.3 Warfarin Replacement

8.3.4 Areas Demanding Attention

8.3.5 Key Market Restraints

8.4 Interview with Dr Jeffrey I. Weitz (Professor of Medicine & Biochemistry, McMaster University, and Executive Director, Thrombosis & Atherosclerosis Research Institute, Ontario)

8.4.1 Unmet Needs

8.4.2 New Oral Anticoagulants

8.4.3 Future Areas of Focus

8.4.4 New Drug Potential

8.4.5 Market Drivers and Restraints

 

9. Conclusions


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Ophthalmic Drugs: World Market Prospects 2012-2022
2. Antibody Drugs: Technologies and Global Markets
3. Antibacterial Drugs: World Market Prospects 2012-2022
4. Generic Drugs: World Market Outlook 2011-2021
5. Multi-therapy Drugs: Opportunities for Generics & Biosimilars
6. Generic Drugs: The Global Market--Focus on Europe
7. Generic Drugs: The Global Market--Focus on Asia
8. Generic Drugs: The Global Market
9. Generic Drugs: The Global Market: Focus on the Americas
10. Reportlinker Adds Leading Anti-Cancer Drugs: World Market Prospects 2011-2021
11. FDA CONSUMER HEALTH INFORMATION - Combating Misuse and Abuse of Prescription Drugs: Q&A with Michael Klein, Ph.D.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... Accelerated orthodontic treatment will be a ... 2015 Annual Session, May 15-19, as seven of ... AcceleDent ® . Manufactured by OrthoAccel ® ... is a FDA-cleared, Class II medical device that ... 50 percent with just 20 minutes of daily ...
(Date:3/31/2015)... 2015 Ryan & Maniskas, LLP ... of Hyperion Therapeutics, Inc. ("Hyperion" or the "Company") (NASDAQ: ... and other violations of law related to the Company,s ... in a transaction valued at approximately $1.1 billion. ... like to learn more about this class action or ...
(Date:3/31/2015)... 2015 Medela has announced the addition ... ® Motion™-Endure personal pumps to its Negative Pressure ... These new devices, along with the Invia ® ... provide innovative, high-quality NPWT solutions, designed to provide ... "We are happy to be able ...
Breaking Medicine Technology:Leading Orthodontists to Advance Accelerated Treatment at AAO 2015 2Leading Orthodontists to Advance Accelerated Treatment at AAO 2015 3Ryan & Maniskas, LLP Announces Investigation of Hyperion Therapeutics, Inc. 2Medela Launches Product Line to Support Individualized Care For Negative Pressure Wound Therapy Patients 2
... BEIJING , July 7 ... "Company"), a growing developer,manufacturer and seller of medicine and drugs in ... will present at the Global Hunter,Securities 2010 China Conference held ... are noted below. , , Date: ...
... BEIJING , July 7 /PRNewswire-Asia-FirstCall/ -- ... CCM ), operator of,the largest network of radiotherapy ... it has filed its annual report for the fiscal year ... U.S. Securities and Exchange,Commission on June 30, 2010 . ...
Cached Medicine Technology:Lotus Pharmaceuticals to Present at Global Hunter Securities 2010 China Conference 2Concord Medical Files 2009 Annual Report on Form 20-F 2
(Date:3/31/2015)... 2015 When SIGVARIS launched the EVERSHEER compression ... product launch to date. Women immediately fell in love with ... another reason to love EVERSHEER with the launch of a ... , Lavender mist pairs perfectly with a variety of navy, ... women looking to add a hint of spring to their ...
(Date:3/31/2015)... The report “Coagulation/Hemostasis Analyzer Market By product ... Prothrombin Time/INR, D-Dimer, Fibrinogen), Technology (Mechanical, Optical), End ... studies the major market drivers, restraints, opportunities and ... Rest of the world (RoW). , The ... $3.58 billion by 2019 from $2.4 billion in ...
(Date:3/31/2015)... Safeware has been recognized ... Central Ohio, an awards program presented by Columbus Business ... the awards program, held on March 10, 2015. These ... health, with outstanding health and wellness initiatives. , ... a healthy environment for their associates. Business Frist, OhioHealth ...
(Date:3/31/2015)... Spring Hill, FL (PRWEB) March 31, 2015 ... and Substance Abuse (CASA) at Columbia University states that ... arrested in the U.S. and enter state juvenile justice ... abuse problems, are under the influence of drugs or ... of these factors. Despite this high incidence of substance-related ...
(Date:3/31/2015)... A' Design Award and Competition is pleased ... Daniel Dion has been announced as a winner of ... Devices and Research Equipment Design Competition Category. ... behind the award winning Medical Product design Bruker EVOQ ... direction of Dr. Rohan Thakur and the Bruker team ...
Breaking Medicine News(10 mins):Health News:Put Spring in Your Step with SIGVARIS’ Top Selling Sheer Hosiery Compression Therapy Brand 2Health News:The Global Coagulation Analyzers Market will be Valued at $3.58 Billion in 2019 - MarketsandMarkets 2Health News:The Global Coagulation Analyzers Market will be Valued at $3.58 Billion in 2019 - MarketsandMarkets 3Health News:The Global Coagulation Analyzers Market will be Valued at $3.58 Billion in 2019 - MarketsandMarkets 4Health News:Safeware Recognized as a Healthiest Employer in Central Ohio 2Health News:$14.4 Billion Annual Price Tag: Suncoast Rehab Center Questions Harsh Sentencing of Juvenile Drug and Alcohol Offenders 2Health News:$14.4 Billion Annual Price Tag: Suncoast Rehab Center Questions Harsh Sentencing of Juvenile Drug and Alcohol Offenders 3Health News:$14.4 Billion Annual Price Tag: Suncoast Rehab Center Questions Harsh Sentencing of Juvenile Drug and Alcohol Offenders 4Health News:Daniel Dion wins Golden in A' Medical Product Design Awards 2
... Osteotech, Inc.,(Nasdaq: OSTE ) announced today that third ... third quarter 2006 revenue of $23.4,million. Revenue from Osteotech,s ... for the three months ended September 30,2007 as compared ... for the,third quarter of 2006. Gross margin improved to ...
... 6 /PRNewswire-FirstCall/ - Bioniche Life Sciences,Inc. (TSX: BNC), ... Cameron Groome, Executive,Vice-President, Corporate & Strategic Development, will ... Healthcare Conference in New York City,tomorrow. Mr. Groome ... the Holmes,II Room of the New York Palace ...
... by web cast-, TORONTO, Nov. 6 /PRNewswire-FirstCall/ ... in the research,development and commercialization of pharmaceutical products ... that on,Wednesday, November 7, 2007, at 10:30 a.m. ... and CEO will present a corporate overview of ...
... Elite Books, TUCSON, Ariz., Nov. 5 We all ... the development of Alzheimer,s Disease and heart,disease, along with a ... In her seminal book, The Apo E Gene Diet: ... Body,s Own Genes,(Elite, Hardcover, $27.95, November 1, 2007), Pamela McDonald, ...
... 5 StatSure Diagnostic,Systems, Inc. (OTC Bulletin Board: ... Administration ("FDA"), through its Center for Devices and,Radiological ... Laboratory,Improvements Amendments of 1988 ("CLIA") for an HIV ... The HIV 1/2 product,is marketed and distributed worldwide ...
... offices could ... YORK, Nov. 5 Group Health Incorporated (GHI) and,HIP ... educational seminar in,New York City on November 6 for ... be held at HIP,headquarters, 55 Water St., will provide ...
Cached Medicine News:Health News:Osteotech Reports 2007 Third Quarter Financial Results; Core Segment Revenue Increased 28%; Gross Margin Improved to 55%; Diluted Earnings Per Share of $.09 2Health News:Osteotech Reports 2007 Third Quarter Financial Results; Core Segment Revenue Increased 28%; Gross Margin Improved to 55%; Diluted Earnings Per Share of $.09 3Health News:Osteotech Reports 2007 Third Quarter Financial Results; Core Segment Revenue Increased 28%; Gross Margin Improved to 55%; Diluted Earnings Per Share of $.09 4Health News:Osteotech Reports 2007 Third Quarter Financial Results; Core Segment Revenue Increased 28%; Gross Margin Improved to 55%; Diluted Earnings Per Share of $.09 5Health News:Bioniche to Present at Rodman & Renshaw 9th Annual Healthcare Conference 2Health News:Lorus announces presentation of corporate overview at the Rodman and Renshaw Annual Healthcare Conference 2Health News:Groundbreaking Apo E Gene Diet Linked to Alzheimer's Disease and Heart Disease Prevention 2Health News:StatSure's Patented HIV 'Barrel' Technology Receives CLIA Waiver From FDA 2Health News:StatSure's Patented HIV 'Barrel' Technology Receives CLIA Waiver From FDA 3Health News:GHI and HIP Lead Effort to Expand Electronic Health Record System Throughout the City of New York 2
... imaging first with the introduction of the ... This breakthrough platform in imaging offers the ... technology available in a mobile system., ,The ... for mobile imaging systems by providing image ...
Stryker Instruments, the leader in surgical helmets, offers its 4th generation of personal protection systems for todays surgical environment the Sterishield T4 System....
... PS Medical Delta valve is designed ... (CSF) and maintain intraventricular pressure (IVP) ... of patient position. The normally closed ... to positive ventricular pressure. Working with ...
... PS Medical Strata valve is an adjustable ... properties of the valve can be changed ... to minimize overdrainage of cerebrospinal fluid (CSF) ... normal physiologic range, regardless of patient position. ...
Medicine Products: